Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Dec;9(12):1373-7.

Side effects associated with the treatment of multidrug-resistant tuberculosis

T Törün  1 , G Güngör, I Ozmen, Y Bölükbaşi, E Maden, B Biçakçi, G Ataç, T Sevim, K Tahaoğlu
Affiliations
  • PMID: 16468160

Side effects associated with the treatment of multidrug-resistant tuberculosis

T Törün et al. Int J Tuberc Lung Dis. 2005 Dec.

Abstract

Setting: Süreyyapaşa Centre for Chest Diseases and Thoracic Surgery, Istanbul, Turkey.

Objective: To report the frequency of treatment side effects in cases of multidrug-resistant (MDR-TB) tuberculosis.

Design: A retrospective review of the medical records of 263 patients who received individualised treatment for MDR-TB between April 1992 and June 2004.

Results: One or more side effects developed in 182 cases (69.2%). These effects led the clinicians to withdraw one or more drugs from the treatment regimen in 146 cases (55.5%). Side effects observed most frequently included: ototoxicity (41.8%), psychiatric disorders (21.3%), gastrointestinal disturbance (14.0%), arthralgia (11.4%), epileptic seizures (9.9%), hepatitis (4.5%), and dermatological effects (4.5%). At the time of analysis, treatment was successful in 204 (77.6%) cases. Fifty-nine patients (22.4%) had poor outcomes.

Conclusion: Timely and aggressive management of drug side effects means that high side effect rates in MDR-TB treatment need not compromise success rates.

PubMed Disclaimer

Substances

LinkOut - more resources